Grazoprevir published presentations and documents on DocSlides.
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
C-WORTHY Study Part C: . grazoprevir. . + . elba...
grazoprevir. . + . elbasvir. . in genotype 1 wi...
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
D : . grazoprevir. . + . elbasvir. + RBV in ge...
. +/- Ribavirin in HCV Genotype 1, 4 or 6. C-EDG...
+ . Grazoprevir. +/- Ribavirin in . Treatment-N...
+ . Grazoprevir. in . GT 1 . and Chronic Renal ...
. + . Sofosbuvir. . in Treatment-Naïve HCV Gen...
X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...
in genotypes 1 or 3, with or without cirrhosis. &...
N = 45. N = 49. W24. W16. MK3. > . 18 years. H...
Randomisation*. Open-label. >. 18 years. HCV ...
in genotypes 1 or 3, with or without cirrhosis. &...
6; 386:1537-45. C-SURFER Study: . grazoprevir. ....
Ribavirin in PI-experienced HCV GT1. C-SALVAGE...
C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...
University of Chicago. Chicago, Illinois. Challen...
C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...
HCV . GT 1,4, or 6 in PWID* on Opiate Agonist Ther...
Kristen M. Marks, MD. Assistant Professor. Weill C...
Copyright © 2024 DocSlides. All Rights Reserved